$SBRA
Sabra Health Care REIT, Inc.

2020 Q1 Form 10-Q Financial Statement

#000149229820000015 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $149.3M $136.8M
YoY Change 9.19% -17.65%
Cost Of Revenue $27.00M $12.00M
YoY Change 125.0% -0.83%
Gross Profit $122.4M $124.7M
YoY Change -1.84% -19.03%
Gross Profit Margin 81.96% 91.17%
Selling, General & Admin $9.300M $9.400M
YoY Change -1.06% 3.3%
% of Gross Profit 7.6% 7.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.17M $44.95M
YoY Change -1.74% -6.37%
% of Gross Profit 36.08% 36.05%
Operating Expenses $58.30M $59.70M
YoY Change -2.35% 4.55%
Operating Profit $64.10M $65.00M
YoY Change -1.38% -32.92%
Interest Expense -$28.90M -$37.70M
YoY Change -23.34% 6.5%
% of Operating Profit -45.09% -58.0%
Other Income/Expense, Net $2.042M -$1.349M
YoY Change -251.37% -157.45%
Pretax Income $39.93M -$75.70M
YoY Change -152.74% -221.03%
Income Tax $1.042M $612.0K
% Of Pretax Income 2.61%
Net Earnings $35.20M -$77.70M
YoY Change -145.3% -224.38%
Net Earnings / Revenue 23.57% -56.81%
Basic Earnings Per Share $0.17 -$0.44
Diluted Earnings Per Share $0.17 -$0.44
COMMON SHARES
Basic Shares Outstanding 205.4M shares 178.4M shares
Diluted Shares Outstanding 206.0M shares 178.4M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.10M $22.90M
YoY Change 136.24% -50.65%
Cash & Equivalents $54.05M $22.87M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $215.9M $142.0M
YoY Change 52.04% -33.05%
LONG-TERM ASSETS
Property, Plant & Equipment $5.363B $5.447B
YoY Change -1.54% -10.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $311.8M $335.7M
YoY Change -7.13% -5.41%
Other Assets $8.400M $280.5M
YoY Change -97.01% 2277.12%
Total Long-Term Assets $5.876B $6.313B
YoY Change -6.92% -6.78%
TOTAL ASSETS
Total Short-Term Assets $215.9M $142.0M
Total Long-Term Assets $5.876B $6.313B
Total Assets $6.092B $6.455B
YoY Change -5.62% -7.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $112.5M $72.90M
YoY Change 54.32% -28.81%
Accrued Expenses $10.00M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.5M $82.90M
YoY Change 35.71% -19.04%
LONG-TERM LIABILITIES
Long-Term Debt $2.479B $3.230B
YoY Change -23.25% -3.89%
Other Long-Term Liabilities $105.2M $91.30M
YoY Change 15.22% -3.39%
Total Long-Term Liabilities $2.585B $3.322B
YoY Change -22.19% -3.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $112.5M $82.90M
Total Long-Term Liabilities $2.585B $3.322B
Total Liabilities $2.697B $3.404B
YoY Change -20.78% -4.32%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.056M $1.784M
YoY Change 15.25% 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.395B $3.046B
YoY Change
Total Liabilities & Shareholders Equity $6.092B $6.455B
YoY Change -5.62% -7.58%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $35.20M -$77.70M
YoY Change -145.3% -224.38%
Depreciation, Depletion And Amortization $44.17M $44.95M
YoY Change -1.74% -6.37%
Cash From Operating Activities $74.82M $53.96M
YoY Change 38.66% -46.92%
INVESTING ACTIVITIES
Capital Expenditures -$67.30M $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$2.600M $6.300M
YoY Change -141.27% -101.83%
Cash From Investing Activities -$69.82M $6.347M
YoY Change -1200.11% -101.23%
FINANCING ACTIVITIES
Cash Dividend Paid $92.39M $80.26M
YoY Change 15.11% -3.05%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $8.948M -$87.47M
YoY Change -110.23% -23.53%
NET CHANGE
Cash From Operating Activities $74.82M $53.96M
Cash From Investing Activities -$69.82M $6.347M
Cash From Financing Activities $8.948M -$87.47M
Net Change In Cash $13.94M -$27.17M
YoY Change -151.32% -94.87%
FREE CASH FLOW
Cash From Operating Activities $74.82M $53.96M
Capital Expenditures -$67.30M $0.00
Free Cash Flow $142.1M $53.96M
YoY Change 163.38% -80.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
205208018 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
205559356 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
205208018 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
205559356 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-34950
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
SABRA HEALTH CARE REIT, INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2560479
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
18500 Von Karman Avenue, Suite 550
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2020Q1 dei City Area Code
CityAreaCode
888
CY2020Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5363168000 USD
CY2019Q4 us-gaap Unsecured Debt
UnsecuredDebt
1248773000 USD
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
393-8248
CY2020Q1 dei Security12b Title
Security12bTitle
Common stock, $.01 par value
CY2020Q1 dei Trading Symbol
TradingSymbol
SBRA
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
205559356 shares
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5341370000 USD
CY2020Q1 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
88370000 USD
CY2019Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
107374000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
311753000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
319460000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54051000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39097000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8375000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10046000 USD
CY2020Q1 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
96758000 USD
CY2019Q4 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
101509000 USD
CY2020Q1 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
169829000 USD
CY2019Q4 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
150443000 USD
CY2020Q1 us-gaap Assets
Assets
6092304000 USD
CY2019Q4 us-gaap Assets
Assets
6069299000 USD
CY2020Q1 us-gaap Secured Debt
SecuredDebt
97066000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
113070000 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
101000000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
1033110000 USD
CY2019Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
1040258000 USD
CY2020Q1 us-gaap Unsecured Debt
UnsecuredDebt
1248170000 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
150926000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
108792000 USD
CY2020Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
66819000 USD
CY2019Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
69946000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
2697091000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
2580839000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
667000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2052000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1207000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4075781000 USD
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2056000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4072079000 USD
CY2020Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
631251000 USD
CY2019Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
573283000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51373000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12388000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3395213000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
3488460000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6092304000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6069299000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
106512000 USD
CY2019Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
116387000 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2851000 USD
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
3325000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39983000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17061000 USD
CY2020Q1 us-gaap Revenues
Revenues
149346000 USD
CY2019Q1 us-gaap Revenues
Revenues
136773000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44168000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44949000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25704000 USD
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
36318000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8761000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8184000 USD
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
103134000 USD
CY2020Q1 sbra Operating And Interest Expense
OperatingAndInterestExpense
111462000 USD
CY2019Q1 sbra Operating And Interest Expense
OperatingAndInterestExpense
211121000 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2259000 USD
CY2019Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
171000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-217000 USD
CY2019Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1520000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2042000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1349000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39926000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75697000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3667000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1383000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1042000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-77692000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
612000 USD
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
36000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14048000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3768000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91752000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3254747000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-77692000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35217000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-77704000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205395330 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
178385984 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206006285 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
178385984 shares
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-77692000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1707000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-560000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-40692000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-13488000 USD
CY2020Q1 sbra Other Comprehensive Income Loss Net Of Tax Including Cumulative Effect Of New Accounting Principle In Period Of Adoption
OtherComprehensiveIncomeLossNetOfTaxIncludingCumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-38985000 USD
CY2019Q1 sbra Other Comprehensive Income Loss Net Of Tax Including Cumulative Effect Of New Accounting Principle In Period Of Adoption
OtherComprehensiveIncomeLossNetOfTaxIncludingCumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-14048000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3768000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-91740000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
12000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3270000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2207000 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
80754000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3050778000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3488460000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38985000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2988000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
718000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
93018000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17265000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3395213000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74819000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-77692000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53959000 USD
CY2020Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
67274000 USD
CY2019Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 USD
CY2020Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
936000 USD
CY2019Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2776000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44168000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44949000 USD
CY2020Q1 sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-365000 USD
CY2019Q1 sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-1164000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
561000 USD
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
562000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2233000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2561000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2360000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2775000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
667000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1207000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-217000 USD
CY2019Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1520000 USD
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
103134000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3667000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1383000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4040000 USD
CY2019Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3037000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6895000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9924000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9929000 USD
CY2020Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
11956000 USD
CY2019Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
5072000 USD
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1011000 USD
CY2019Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
5251000 USD
CY2020Q1 sbra Repaymentsof Preferred Equity Investments
RepaymentsofPreferredEquityInvestments
-3059000 USD
CY2019Q1 sbra Repaymentsof Preferred Equity Investments
RepaymentsofPreferredEquityInvestments
-2087000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
6272000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
6857000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69824000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6347000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
101000000 USD
CY2020Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
715000 USD
CY2019Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6000 USD
CY2020Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2019Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
36000 USD
CY2020Q1 sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
1930000 USD
CY2019Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
849000 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-4000000 USD
CY2020Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
877000 USD
CY2019Q1 sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
-2323000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
92390000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
80260000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8948000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-87474000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13943000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-27168000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-660000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49143000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59658000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62426000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32639000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
21526000 USD
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
42195000 USD
CY2020Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
16092000 USD
CY2019Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0 USD
CY2020Q1 sbra Real Estate Investments Joint Ventures Number
RealEstateInvestmentsJointVenturesNumber
0 Investment
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></div>
CY2019Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
239229000 USD
CY2020Q1 us-gaap Land Improvements
LandImprovements
1535000 USD
CY2019Q4 us-gaap Land Improvements
LandImprovements
1534000 USD
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain amounts in the Company’s condensed consolidated statements of income and condensed consolidated statements of cash flows for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations.</span></div>
CY2020Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5932920000 USD
CY2020Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
569752000 USD
CY2020Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5363168000 USD
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5880583000 USD
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
539213000 USD
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5341370000 USD
CY2020Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5093517000 USD
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5042435000 USD
CY2020Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
241407000 USD
CY2020Q1 us-gaap Land
Land
596461000 USD
CY2019Q4 us-gaap Land
Land
597385000 USD
CY2020Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5932920000 USD
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5880583000 USD
CY2020Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
569752000 USD
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
539213000 USD
CY2020Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5363168000 USD
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5341370000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2020Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
10100000 USD
CY2019Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
10500000 USD
CY2020Q1 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
17800000 USD
CY2019Q4 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
14300000 USD
CY2020Q1 us-gaap Variable Lease Income
VariableLeaseIncome
5200000 USD
CY2019Q1 us-gaap Variable Lease Income
VariableLeaseIncome
4200000 USD
CY2020Q1 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
84000000 USD
CY2019Q4 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
83000000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
319956000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
427122000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
406769000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
392007000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
383326000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
1742840000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3672020000 USD
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
103100000 USD
CY2020Q1 sbra Financing Receivable Numberof Loans
FinancingReceivableNumberofLoans
19 loan
CY2020Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
67545000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
63618000 USD
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
63634000 USD
CY2020Q1 sbra Financing Receivable Fixed Interest Rate
FinancingReceivableFixedInterestRate
0.077
CY2020Q1 sbra Financing Receivable Effective Interest Rate
FinancingReceivableEffectiveInterestRate
0.079
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1225000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
564000 USD
CY2020Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
67545000 USD
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
62393000 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
63070000 USD
CY2020Q1 sbra Preferred Equity Investments Number
PreferredEquityInvestmentsNumber
6 preferred_equity_investment
CY2020Q1 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
25793000 USD
CY2020Q1 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
25977000 USD
CY2019Q4 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
44304000 USD
CY2020Q1 sbra Preferred Equity Investment Weighted Average Contractual Rate
PreferredEquityInvestmentWeightedAverageContractualRate
0.124
CY2020Q1 sbra Investments Weighted Average Contractual Rate
InvestmentsWeightedAverageContractualRate
0.090
CY2020Q1 sbra Investments Weighted Average Effective Rate
InvestmentsWeightedAverageEffectiveRate
0.092
CY2020Q1 sbra Preferred Equity Investment Weighted Average Effective Rate
PreferredEquityInvestmentWeightedAverageEffectiveRate
0.124
CY2020Q1 sbra Numberof Investments
NumberofInvestments
25 Investment
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
107816000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
453898000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
891195000 USD
CY2020Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
93338000 USD
CY2020Q1 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
88370000 USD
CY2019Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
107374000 USD
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
39000 USD
CY2018Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
449000 USD
CY2020Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
8000 USD
CY2019Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
218000 USD
CY2020Q1 sbra Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Reduction Due To Payoff
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesReductionDueToPayoff
0 USD
CY2019Q1 sbra Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Reduction Due To Payoff
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesReductionDueToPayoff
33000 USD
CY2020Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
31000 USD
CY2019Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
198000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
700000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1200000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25700000 USD
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
36300000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2200000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2600000 USD
CY2020Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
18600000 USD
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16700000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2387000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
17205000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1020073000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2492574000 USD
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-7325000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
20553000 USD
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
2479346000 USD
CY2020Q1 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-28475000 USD
CY2019Q1 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-14770000 USD
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
8074000 USD
CY2020Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2020Q1 us-gaap Derivative Assets
DerivativeAssets
8074000 USD
CY2020Q1 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
8074000 USD
CY2020Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q1 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
38411000 USD
CY2020Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
38411000 USD
CY2020Q1 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
8074000 USD
CY2020Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2020Q1 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
30337000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
7477000 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2019Q4 us-gaap Derivative Assets
DerivativeAssets
7477000 USD
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
544000 USD
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
6933000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
626000 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
626000 USD
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
544000 USD
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
82000 USD
CY2020Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
67545000 USD
CY2019Q4 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
67527000 USD
CY2020Q1 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
25793000 USD
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
610955 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019Q4 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
43893000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
900000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1300000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35217000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-77704000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205395330 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
178385984 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206006285 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
178385984 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44

Files In Submission

Name View Source Status
0001492298-20-000015-index-headers.html Edgar Link pending
0001492298-20-000015-index.html Edgar Link pending
0001492298-20-000015.txt Edgar Link pending
0001492298-20-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
sbra-20200331.xsd Edgar Link pending
sbra-20200331_cal.xml Edgar Link unprocessable
sbra-20200331_def.xml Edgar Link unprocessable
sbra-20200331_lab.xml Edgar Link unprocessable
sbra-20200331_pre.xml Edgar Link unprocessable
sbra10q2020q1.htm Edgar Link pending
sbra10q2020q1_htm.xml Edgar Link completed
sbraex3112020q1.htm Edgar Link pending
sbraex3122020q1.htm Edgar Link pending
sbraex3212020q1.htm Edgar Link pending
sbraex3222020q1.htm Edgar Link pending
Show.js Edgar Link pending